Ranbaxy at a Glance

At a Glance

Team Size About 2,500 persons
Ranbaxy Sales US $ 299 Mn
Total No. of Molecules
Ranbaxy + Local tie ups
Market formulations based on more than 200 molecules (including Fixed Dose Combinations)
Lead Molecules

Cephalexin (Sporidex), Ciprofloxacin (Cifran), Amoxycillin (Mox), Ofloxacin (Zanocin), Atorvastatin (Storvas), Ceftriaxone (Oframax), Cefpodoxime (Cepodem), Co-amoxyclav (Moxclav), Cilanem (Imipenem+Cilastatin), Volini (Diclofenac combination), Silverex (Silver Sulphadizine), Cepodem (Cefpodoxime), Verorab (Rabies vaccine)

Presence in Therapeutic Segments Anti-Infectives, Cardiovascular & Diabetes, Dermatological, Neuro-Psychiatry, Pain management, Gastro-Intestinal, Nutritional
November 1, 2010

1 responses on "Ranbaxy at a Glance"

  1. Useful information, cheers to your author. It can be puzzling in my experience now, employing general, the usefulness and importance has my head spinning. Completely thanks again and best of luck!

Leave a Message

Your email address will not be published. Required fields are marked *


Join fastest growing subscribers who benefit from PharmaCrunch’s coverage on "Pharmaceuticals - Must to Know" updates

Testimonial from Subscribers

Read more

Pradeep Agarwal

Marketing - AstraZeneca
2016 © PharmaCrunch All rights reserved
Skip to toolbar